Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study

Authors:

Abstract
No abstract available
Funding Information
  • BioMarin Pharmaceutical

This publication has 21 references indexed in Scilit: